Selected research
Industry Growth & Trends
Global Molecular Diagnostics Tests & Reagents Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Molecular Diagnostics Tests & Reagents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Molecular Diagnostics Tests & Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Molecular Diagnostics Tests & Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Molecular Diagnostics Tests & Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Molecular Diagnostics Tests & Reagents market include Abbott Laboratories, Shanghai Kehua Bio-engineering, Johnson and Johnson, Merck Millipore, Beijing Leadman Biochemistry, Thermo Scientific, Sysmex Corporation, Siemens Healthcare and Roche Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Molecular Diagnostics Tests & Reagents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Molecular Diagnostics Tests & Reagents market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Molecular Diagnostics Tests & Reagents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Molecular Diagnostics Tests & Reagents.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Molecular Diagnostics Tests & Reagents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Molecular Diagnostics Tests & Reagents Market by Company
Abbott Laboratories
Shanghai Kehua Bio-engineering
Johnson and Johnson
Merck Millipore
Beijing Leadman Biochemistry
Thermo Scientific
Sysmex Corporation
Siemens Healthcare
Roche Diagnostics
Ortho Clinical Diagnostics
Mindray
Danaher Corporation
DAAN Gene
Cobas
Caprion
BioSino Bio-technology
Bio-Rad Laboratories
Biomerieux
Becton Dickinson
Beckman Coulter Inc
Aptiv Solution
Molecular Diagnostics Tests & Reagents Segment by Type
Professional Diagnostic
Diabetes Monitoring
Molecular Diagnostic
Molecular Diagnostics Tests & Reagents Segment by Application
HIV
Infectious Diseases
Diabetes
Cardiology
Oncology
Other
Molecular Diagnostics Tests & Reagents Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostics Tests & Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostics Tests & Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostics Tests & Reagents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Molecular Diagnostics Tests & Reagents companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Professional Diagnostic
- Diabetes Monitoring
- Molecular Diagnostic
Applications
- HIV
- Infectious Diseases
- Diabetes
- Cardiology
- Oncology
- Other
Companies covered
- Abbott Laboratories
- Shanghai Kehua Bio-engineering
- Johnson and Johnson
- Merck Millipore
- Beijing Leadman Biochemistry
- Thermo Scientific
- Sysmex Corporation
- Siemens Healthcare
- Roche Diagnostics
- Ortho Clinical Diagnostics
- Mindray
- Danaher Corporation
- DAAN Gene
- Cobas
- Caprion
- BioSino Bio-technology
- Bio-Rad Laboratories
- Biomerieux
- Becton Dickinson
- Beckman Coulter Inc
- Aptiv Solution
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Molecular Diagnostics Tests & Reagents Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Molecular Diagnostics Tests & Reagents Market Size by Region (2021-2032)
- 1.4.1 Global Molecular Diagnostics Tests & Reagents Market Size by Region (2021-2026)
- 1.4.2 Global Molecular Diagnostics Tests & Reagents Market Size by Region (2027-2032)
- 1.5 Key Regions Molecular Diagnostics Tests & Reagents Market Size (2021-2032)
- 1.5.1 North America Molecular Diagnostics Tests & Reagents Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Molecular Diagnostics Tests & Reagents Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size Growth Rate (2021-2032)
- 1.5.4 South America Molecular Diagnostics Tests & Reagents Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size Growth Rate (2021-2032)
2 Molecular Diagnostics Tests & Reagents Market by Type
- 2.1 Type Introduction
- 2.1.1 Professional Diagnostic
- 2.1.2 Diabetes Monitoring
- 2.1.3 Molecular Diagnostic
- 2.2 Global Molecular Diagnostics Tests & Reagents Market Size by Type
- 2.2.1 Global Molecular Diagnostics Tests & Reagents Market Size Overview by Type (2021-2032)
- 2.2.2 Global Molecular Diagnostics Tests & Reagents Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Molecular Diagnostics Tests & Reagents Market Size Forecasted by Type (2027-2032)
- 2.3 Global Molecular Diagnostics Tests & Reagents Market Size by Regions
- 2.3.1 North America Molecular Diagnostics Tests & Reagents Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Molecular Diagnostics Tests & Reagents Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Molecular Diagnostics Tests & Reagents Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Molecular Diagnostics Tests & Reagents Market Size Breakdown by Type (2021-2026)
3 Molecular Diagnostics Tests & Reagents Market by Application
- 3.1 Type Introduction
- 3.1.1 HIV
- 3.1.2 Infectious Diseases
- 3.1.3 Diabetes
- 3.1.4 Cardiology
- 3.1.5 Oncology
- 3.1.6 Other
- 3.2 Global Molecular Diagnostics Tests & Reagents Market Size by Application
- 3.2.1 Global Molecular Diagnostics Tests & Reagents Market Size Overview by Application (2021-2032)
- 3.2.2 Global Molecular Diagnostics Tests & Reagents Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Molecular Diagnostics Tests & Reagents Market Size Forecasted by Application (2027-2032)
- 3.3 Global Molecular Diagnostics Tests & Reagents Market Size by Regions
- 3.3.1 North America Molecular Diagnostics Tests & Reagents Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Molecular Diagnostics Tests & Reagents Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Molecular Diagnostics Tests & Reagents Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Molecular Diagnostics Tests & Reagents Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Molecular Diagnostics Tests & Reagents Industry Trends
- 4.2 Molecular Diagnostics Tests & Reagents Industry Drivers
- 4.3 Molecular Diagnostics Tests & Reagents Industry Opportunities and Challenges
- 4.4 Molecular Diagnostics Tests & Reagents Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Molecular Diagnostics Tests & Reagents Revenue (2021-2026)
- 5.2 Global Molecular Diagnostics Tests & Reagents Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Molecular Diagnostics Tests & Reagents Key Company Headquarters & Area Served
- 5.4 Global Molecular Diagnostics Tests & Reagents Company, Product Type & Application
- 5.5 Global Molecular Diagnostics Tests & Reagents Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Molecular Diagnostics Tests & Reagents Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Molecular Diagnostics Tests & Reagents Players Market Share by Revenue in 2025
- 5.6.3 2025 Molecular Diagnostics Tests & Reagents Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott Laboratories
- 6.1.1 Abbott Laboratories Company Information
- 6.1.2 Abbott Laboratories Business Overview
- 6.1.3 Abbott Laboratories Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.1.5 Abbott Laboratories Recent Developments
- 6.2 Shanghai Kehua Bio-engineering
- 6.2.1 Shanghai Kehua Bio-engineering Company Information
- 6.2.2 Shanghai Kehua Bio-engineering Business Overview
- 6.2.3 Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.2.5 Shanghai Kehua Bio-engineering Recent Developments
- 6.3 Johnson and Johnson
- 6.3.1 Johnson and Johnson Company Information
- 6.3.2 Johnson and Johnson Business Overview
- 6.3.3 Johnson and Johnson Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Johnson and Johnson Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.3.5 Johnson and Johnson Recent Developments
- 6.4 Merck Millipore
- 6.4.1 Merck Millipore Company Information
- 6.4.2 Merck Millipore Business Overview
- 6.4.3 Merck Millipore Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Merck Millipore Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.4.5 Merck Millipore Recent Developments
- 6.5 Beijing Leadman Biochemistry
- 6.5.1 Beijing Leadman Biochemistry Company Information
- 6.5.2 Beijing Leadman Biochemistry Business Overview
- 6.5.3 Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.5.5 Beijing Leadman Biochemistry Recent Developments
- 6.6 Thermo Scientific
- 6.6.1 Thermo Scientific Company Information
- 6.6.2 Thermo Scientific Business Overview
- 6.6.3 Thermo Scientific Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Thermo Scientific Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.6.5 Thermo Scientific Recent Developments
- 6.7 Sysmex Corporation
- 6.7.1 Sysmex Corporation Company Information
- 6.7.2 Sysmex Corporation Business Overview
- 6.7.3 Sysmex Corporation Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Sysmex Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.7.5 Sysmex Corporation Recent Developments
- 6.8 Siemens Healthcare
- 6.8.1 Siemens Healthcare Company Information
- 6.8.2 Siemens Healthcare Business Overview
- 6.8.3 Siemens Healthcare Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Siemens Healthcare Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.8.5 Siemens Healthcare Recent Developments
- 6.9 Roche Diagnostics
- 6.9.1 Roche Diagnostics Company Information
- 6.9.2 Roche Diagnostics Business Overview
- 6.9.3 Roche Diagnostics Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Roche Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.9.5 Roche Diagnostics Recent Developments
- 6.10 Ortho Clinical Diagnostics
- 6.10.1 Ortho Clinical Diagnostics Company Information
- 6.10.2 Ortho Clinical Diagnostics Business Overview
- 6.10.3 Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.10.5 Ortho Clinical Diagnostics Recent Developments
- 6.11 Mindray
- 6.11.1 Mindray Company Information
- 6.11.2 Mindray Business Overview
- 6.11.3 Mindray Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Mindray Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.11.5 Mindray Recent Developments
- 6.12 Danaher Corporation
- 6.12.1 Danaher Corporation Company Information
- 6.12.2 Danaher Corporation Business Overview
- 6.12.3 Danaher Corporation Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Danaher Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.12.5 Danaher Corporation Recent Developments
- 6.13 DAAN Gene
- 6.13.1 DAAN Gene Company Information
- 6.13.2 DAAN Gene Business Overview
- 6.13.3 DAAN Gene Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 DAAN Gene Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.13.5 DAAN Gene Recent Developments
- 6.14 Cobas
- 6.14.1 Cobas Company Information
- 6.14.2 Cobas Business Overview
- 6.14.3 Cobas Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Cobas Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.14.5 Cobas Recent Developments
- 6.15 Caprion
- 6.15.1 Caprion Company Information
- 6.15.2 Caprion Business Overview
- 6.15.3 Caprion Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Caprion Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.15.5 Caprion Recent Developments
- 6.16 BioSino Bio-technology
- 6.16.1 BioSino Bio-technology Company Information
- 6.16.2 BioSino Bio-technology Business Overview
- 6.16.3 BioSino Bio-technology Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 BioSino Bio-technology Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.16.5 BioSino Bio-technology Recent Developments
- 6.17 Bio-Rad Laboratories
- 6.17.1 Bio-Rad Laboratories Company Information
- 6.17.2 Bio-Rad Laboratories Business Overview
- 6.17.3 Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.17.5 Bio-Rad Laboratories Recent Developments
- 6.18 Biomerieux
- 6.18.1 Biomerieux Company Information
- 6.18.2 Biomerieux Business Overview
- 6.18.3 Biomerieux Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Biomerieux Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.18.5 Biomerieux Recent Developments
- 6.19 Becton Dickinson
- 6.19.1 Becton Dickinson Company Information
- 6.19.2 Becton Dickinson Business Overview
- 6.19.3 Becton Dickinson Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Becton Dickinson Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.19.5 Becton Dickinson Recent Developments
- 6.20 Beckman Coulter Inc
- 6.20.1 Beckman Coulter Inc Company Information
- 6.20.2 Beckman Coulter Inc Business Overview
- 6.20.3 Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.20.5 Beckman Coulter Inc Recent Developments
- 6.21 Aptiv Solution
- 6.21.1 Aptiv Solution Company Information
- 6.21.2 Aptiv Solution Business Overview
- 6.21.3 Aptiv Solution Molecular Diagnostics Tests & Reagents Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Aptiv Solution Molecular Diagnostics Tests & Reagents Product Portfolio
- 6.21.5 Aptiv Solution Recent Developments
7 North America
- 7.1 North America Molecular Diagnostics Tests & Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
- 7.3 North America Molecular Diagnostics Tests & Reagents Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Molecular Diagnostics Tests & Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
- 8.3 Europe Molecular Diagnostics Tests & Reagents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Molecular Diagnostics Tests & Reagents Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Molecular Diagnostics Tests & Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
- 10.3 South America Molecular Diagnostics Tests & Reagents Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Molecular Diagnostics Tests & Reagents Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst